You are on Trendlyne United States. Click here to go to India website or make United States as your default
person reading

About Curis Inc - Company Information, Overview, History and Profile

What does Curis Inc do?

Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Curis Inc Management structure

All Gross Remunerations are in USD
Mr. James E. Dentzer
Director, President and Chief Executive Officer
-
2024
Gross Remuneration
Year
Ms. Diantha Duvall
Chief Financial Officer and Principal Accounting Officer
-
2024
Gross Remuneration
Year
Mr. Jonathan B. Zung, PhD
Chief Development Officer
-
2024
Gross Remuneration
Year

Curis Inc Board of directors

All Gross Remunerations are in USD
Mr. James E. Dentzer
Director, President and Chief Executive Officer
-
2024
Gross Remuneration
Year
Dr. Kenneth I. Kaitin,PhD
Independent Director
-
2024
Gross Remuneration
Year
Dr. Marc Rubin,M.D.
Independent Director
-
2024
Gross Remuneration
Year
Mr. Martyn D. Greenacre
Chairman of the Board
-
2024
Gross Remuneration
Year
Dr. John A. Hohneker, M.D.
Independent Director
-
2024
Gross Remuneration
Year
Dr. Anne E. Borgman, M.D.
Independent Director
-
2024
Gross Remuneration
Year